✦ LIBER ✦

A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer

✍ Scribed by Junji Furuse; Takuji Okusaka; Shinichi Ohkawa; Michitaka Nagase; Akihiro Funakoshi; Narikazu Boku; Kenji Yamao; Taketo Yamaguchi; Toshiya Sato

Book ID: 105993159
Publisher: Springer
Year: 2009
Tongue: English
Weight: 324 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1011-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of uracil-tegafur plus ci

Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer

✍ Koichi TAKAYAMA; Masayuki KAWASAKI; Kiyoshi NINOMIYA; Akira MOTOHIRO; Masaki FUJ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

A phase II trial of oral tegafur and ura

A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer

✍ Yukito Ichinose; Nobuko Takanashi; Tokujiro Yano; Hiroshi Asoh; Hideki Yokoyama; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu

Phase II study of erlotinib plus gemcita

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer

✍ Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Phase II study of doxorubicin plus ifosf

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer

✍ Michael J. Millward; Adrian L. Harris; Brian M. J. Cantwell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 1 views

Phase II study of hepatic intraarterial

Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors

✍ Maurizio Cantore; Andrea Mambrini; Giammaria Fiorentini; Carla Rabbi; Donatella 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

A multiple-center phase II study of biwe

A multiple-center phase II study of biweekly oxaliplatin and tegafur–uracil/leucovorin for chemonaive patients with advanced gastric cancer

✍ Jen-Shi Chen; Kun-Ming Rau; Yen-Yang Chen; Jen-Seng Huang; Tsai-Shen Yang; Yung- 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 276 KB